Kathleen Jentsch‐Ullrich

Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults—A monocentric German study

Kathleen Jentsch‐Ullrich, Michael Koenigsmann, Martin Mohren et al. · Clinical Immunology · 2005 · 189 citations

Life Sciences, Immunology, Cellular Immunology +12

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Thromboembolic complications after splenectomy for hematologic diseases

Martin Mohren, Ilka Markmann, Ulrike Dworschak et al. · American Journal of Hematology · 2004 · 114 citations · Full text

Medicine, Hematology, Surgery +16

Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation

Stefanie Zschäbitz, Felix Lasitschka, Boris Hadaschik et al. · European Journal of Cancer · 2017 · 79 citations

Medicine, Immunology, Oncology +13

Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

Martin Mohren, Ilka Markmann, Kathleen Jentsch‐Ullrich et al. · British Journal of Cancer · 2005 · 78 citations · Full text

Medicine, Hematology, Oncology +14